trial
as of 2026-07-01Piloting MOL Intervention for Neuroleptic Decision Making
NCTId NCT03537040
at a glance
— · Completed
Enrollment 5 (actual)
Sponsored by University of Manchester
Primary completion 2019-03-23
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
5 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2018-06-27
Primary completion
2019-03-23
Eligibility
ALL · 16 Years
Interventions & indications
Sponsors
University of ManchesterLead Sponsor
Investigators
1
Sara Tai, DClinPsyPrincipal Investigator
Sites
2 total
Preston, United KingdomManchester, United Kingdom
Facts & assertions
4 sourced
Enrollment
5
Phase
NA
Primary Completion Date
2019-03-23
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person